Trial · NCT07914647
Remote Ischaemic Conditioning for Fatigue After Stroke 2 (RICFAST 2)
NCT07914647, Phase 2, Recruiting, Sheffield Teaching Hospitals NHS Foundation Trust
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Remote Ischaemic Conditioning for Fatigue After Stroke 2 (RICFAST 2). Trials, record NCT07914647. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07914647
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Remote Ischaemic Conditioning for Fatigue After Stroke 2 (RICFAST 2)
- NCT number
- NCT07914647
- Status
- Recruiting
- Phases
- Phase 2
- Enrollment
- 60 participants, estimated
- Lead sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Conditions
- Stroke, Fatigue
- Interventions
- Remote ischaemic conditioning, Sham RIC
- First posted
- 2026-11-03
- Last updated
- 2026-11-03
Source ClinicalTrials.gov
Registered outcomes19
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Adverse events and serious adverse events | From enrolment to the end of the study at 24 weeks | Measures of safety associated with the intervention |
| Primary | Acceptability | From enrolment to end of study at 24 weeks | Likert scale (1= none; 5 = extremely severe) rating of symptoms related to RIC via treatment logs. Less than a third of participants reporting at least moderate discomfort (mean score ≥ 3), as well as from qualitative semi-structured interviews with participants completing the study. |
| Primary | Compliance | From enrolment to end of study at 24 weeks | = \> 80% intended treatment sessions completed. |
| Secondary | Fatigue Severity Score | From enrolment to end of treatment at 12 weeks | Mean change in FSS from baseline to end of treatment will be recorded. |
| Secondary | Modified Fatigue Impact Scale | From enrolment to end of treatment at 12 weeks | MFIS is a secondary measure of fatigue used to characterise fatigue symptom profiles |
| Secondary | Barthel Index | From enrolment to end of treatment at 12 weeks | The Barthel Index is a clinical assessment tool that measures a patient's level of functional independence in basic activities of daily living (ADLs) and mobility |
| Secondary | Modified Rankin Score | From enrolment to end of treatment at 12 weeks | a 7-point clinical tool used to measure the degree of disability or dependence in daily activities for patients who have suffered a stroke or other neurological conditions. |
| Secondary | Generalised Anxiety and Depression Score | From enrolment to end of treatment at 12 weeks | Measure of Anxiety |
| Secondary | Physical Health Questionnaire 9 | From enrolment to end of treatment at 12 weeks | Measure of Depression |
| Secondary | Stroke Impact Scale | From enrolment to end of treatment at 12 weeks | Stroke Specific Quality of Life Measure |
1 to 10 of 19Source ClinicalTrials.gov
See all 19 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07914647
GET https://conductscience.org/api/trials/v1/NCT07914647/registered